Skip to main content

Closed

JAZZ: Jazz Pharmaceuticals plc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+6.1% / yr

Operating margin11.1%

ROIC-0.6%

Financially safe

Adequate

Debt / equity1.20×

Interest coverage2.4×

Current ratio2.04×

Valuation

Unrated

P/E ratio630.2×

Jazz Pharmaceuticals plc

JAZZNASDAQ·USD·Closed

Jazz Pharmaceuticals plc

JAZZNASDAQ·USD·Closed

$252.86

−2.14%

$252.86

−$5.52 (2.14%)

52W Range

95thpctl

Volume

0.64×avg

Mkt Cap

15.88BUSD

P/E

630.2TTM

Div Yield

–ann

52W Range

95thpctl

Volume

0.64×avg

Market Cap

15.88BUSD

P/E Ratio

630.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings